Akèy › Maladi kadyovaskilè
Etid klinik pou Maladi kadyovaskilè ap rekrite nan Etazini
216 etid pou Maladi kadyovaskilè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA36 etid
- New York City, NY32 etid
- Washington, DC29 etid
- Houston, TX24 etid
- Dallas, TX23 etid
- Cleveland, OH22 etid
- Atlanta, GA22 etid
- Philadelphia, PA21 etid
- Chicago, IL21 etid
- St. Louis, MO20 etid
- Pittsburgh, PA20 etid
- Nashville, TN19 etid
- San Francisco, CA18 etid
- Los Angeles, CA18 etid
- Durham, NC17 etid
- Birmingham, AL17 etid
- Ann Arbor, MI16 etid
- Indianapolis, IN16 etid
- Phoenix, AZ16 etid
- Cincinnati, OH16 etid
- Charleston, SC15 etid
- Minneapolis, MN15 etid
- San Diego, CA15 etid
- Jacksonville, FL15 etid
- Rochester, MN15 etid
- Columbus, OH14 etid
- Kansas City, KS14 etid
- Orlando, FL14 etid
- Winston-Salem, NC14 etid
- Richmond, VA13 etid
- Baltimore, MD13 etid
- Salt Lake City, UT13 etid
- Arlington, VA13 etid
- Tampa, FL13 etid
- Portland, OR13 etid
- Tucson, AZ12 etid
- The Bronx, NY12 etid
- Detroit, MI11 etid
- San Antonio, TX11 etid
- Harrisburg, PA11 etid
Pa eta
- Alabama22 etid
- Arizona26 etid
- Arkansas9 etid
- Colorado17 etid
- Connecticut17 etid
- Distrik Columbia11 etid
- Florid36 etid
- Georgia27 etid
- Idaho4 etid
- Illinois31 etid
- Indiana19 etid
- Iowa8 etid
- Kalifòni52 etid
- Kansas18 etid
- Kentucky15 etid
- Lwizyàn16 etid
- Main5 etid
- Maryland31 etid
- Massachusetts38 etid
- Michigan30 etid
- Minnesota31 etid
- Mississippi10 etid
- Missouri26 etid
- Montana3 etid
- Nebraska10 etid
- Nevada7 etid
- New Hampshire5 etid
- New Jersey23 etid
- New Mexico10 etid
- New York41 etid
- North Carolina30 etid
- North Dakota4 etid
- Ohio37 etid
- Oklahoma11 etid
- Oregon14 etid
- Pennsylvania35 etid
- Rhode Island5 etid
- South Carolina21 etid
- South Dakota8 etid
- Tennessee28 etid
- Texas38 etid
- Utah19 etid
- Vermont5 etid
- Virginia25 etid
- Washington15 etid
- West Virginia10 etid
- Wisconsin15 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05897632Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Sep 29, 2026 · NCT07585968Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06244199kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) Pilot
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT07631078Diabetes and Heart Disease Risk in Blacks
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001853Obstructive Sleep Apnea Among Somali-Americans
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT04124848New Heart Imaging Techniques to Evaluate Possible Heart Disease
Ap rekriteVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01399385Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Sep 28, 2026 · NCT07286578Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Sep 28, 2026 · NCT06811896Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07843004ADAPT Micro-Randomized Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06915220Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 23, 2026 · NCT07613099Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Ap rekriteVolontè an sante akeyi
Laj 18 a 35 · Tout sèks · Mizajou Sep 23, 2026 · NCT04916327NightWare and Cardiovascular Health in Veterans With PTSD
Ap rekriteVolontè an sante akeyi
Laj 22 a 88 · Tout sèks · Mizajou Sep 22, 2026 · NCT06419959Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 100 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT02543996A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Ap rekriteFaz 3
Laj 45 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07613294Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention
Ap rekriteEtid obsèvasyonVolontè an sante akeyiMande peman pou patisipan yo
Laj 19 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT01927783Treatment With Aspirin After Preeclampsia: TAP Trial
Ap rekriteFaz 4
Laj 18 a 55 · Fanm · Mizajou Sep 22, 2026 · NCT06281665CV CARE: CardioVascular Care in PC Patients
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT06202820Improving the Collaborative Health of Adult Dyads
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05370014Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 18, 2026 · NCT05440422Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.